Skip to main content
. Author manuscript; available in PMC: 2016 Jun 27.
Published in final edited form as: JCI Insight. 2016 Jun 2;1(8):e85888. doi: 10.1172/jci.insight.85888

Figure 4. Increased renal expression of DRD2 in mice treated with DRD2 AAV.

Figure 4

Renal cortical expression of dopamine D2 receptor (DRD2, 55 kDa) determined by immunoblot in mice treated with NSsiRNA or Drd2 siRNA by left renal subcapsular infusion via osmotic pump for 28 days and treated with control adeno-associated virus (CAAV) or DRD2 AAV (1 × 1011 viral genome particles) by retrograde left ureteral infusion for 14 days after starting the siRNA treatment. n = 3 per group, *P < 0.05 vs. CAAV+NSsiRNA, 1-way ANOVA and Tukey test. NSsiRNA, nonsilencing siRNA.